검색
HCW Biologics Inc
HCWB관심 목록에 추가
1.070USD
+0.733+217.57%
시장 운영 시간 （ET）시세는 15분 지연됩니다
2.81M시가총액
손실P/E TTM
자세한 내용은 HCW Biologics Inc 회사
HCW Biologics Inc. is a clinical-stage biopharmaceutical company. It is focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation, and age-related diseases, such as cancer, cardiovascular diseases, diabetes, neurodegenerative diseases, autoimmune diseases, as well as other conditions. It has developed a Tissue factOr-Based fusion (TOBI) discovery platform to generate designer, novel multi-functional fusion molecules with immunotherapeutic properties. Its lead product candidates include HCW9218 and HCW9302. HCW9218 is a clinical-stage bifunctional molecule that is designed to impact senescence by reducing senescent cells. The Company is prepared to progress HCW9218 in Phase II clinical trials for non-oncology indications.HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes. Its other product candidates include HCW9201, HCW9206, HCW11-006, and others.
HCW Biologics Inc 정보
종목 코드 HCWB
회사 이름HCW Biologics Inc
상장일Jul 20, 2021
CEOWong (Hing C)
직원 수36
유형Ordinary Share
회계 연도 종료Jul 20
주소2929 N Commerce Pkwy
도시MIRAMAR
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호33025
전화19548422024
웹사이트https://hcwbiologics.com/
종목 코드 HCWB
상장일Jul 20, 2021
CEOWong (Hing C)
HCW Biologics Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. Hing C. Wong, Ph.D.
Dr. Hing C. Wong, Ph.D.
Chief Executive Officer, Founder, Director
Chief Executive Officer, Founder, Director
501.91K
--
Ms. Rebecca Byam
Ms. Rebecca Byam
Chief Financial Officer
Chief Financial Officer
43.01K
--
Mr. Scott T. Garrett
Mr. Scott T. Garrett
Independent Chairman of the Board
Independent Chairman of the Board
25.50K
--
Mr. Lee Flowers
Mr. Lee Flowers
Senior Vice President - Business Development
Senior Vice President - Business Development
5.72K
+16.82%
Dr. Peter Rhode, Ph.D.
Dr. Peter Rhode, Ph.D.
Chief Scientific Officer, Vice President - Clinical Operations
Chief Scientific Officer, Vice President - Clinical Operations
1.94K
--
Ms. Lisa M. Giles
Ms. Lisa M. Giles
Independent Director
Independent Director
896.00
--
Mr. Rick S. Greene
Mr. Rick S. Greene
Independent Director
Independent Director
--
--
이름
이름/직위
직위
주식 보유
변동
Dr. Hing C. Wong, Ph.D.
Dr. Hing C. Wong, Ph.D.
Chief Executive Officer, Founder, Director
Chief Executive Officer, Founder, Director
501.91K
--
Ms. Rebecca Byam
Ms. Rebecca Byam
Chief Financial Officer
Chief Financial Officer
43.01K
--
Mr. Scott T. Garrett
Mr. Scott T. Garrett
Independent Chairman of the Board
Independent Chairman of the Board
25.50K
--
Mr. Lee Flowers
Mr. Lee Flowers
Senior Vice President - Business Development
Senior Vice President - Business Development
5.72K
+16.82%
Dr. Peter Rhode, Ph.D.
Dr. Peter Rhode, Ph.D.
Chief Scientific Officer, Vice President - Clinical Operations
Chief Scientific Officer, Vice President - Clinical Operations
1.94K
--
Ms. Lisa M. Giles
Ms. Lisa M. Giles
Independent Director
Independent Director
896.00
--
수익 분석
기업이 아직 관련 데이터를 공개하지 않았습니다.
기업이 아직 관련 데이터를 공개하지 않았습니다.
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.
주식 보유 통계
마지막 업데이트: Thu, May 14
마지막 업데이트: Thu, May 14
주주
주주 유형
주주
주주
비율
Wong (Hing C)
7.45%
Armistice Capital LLC
4.46%
Byam (Rebecca)
0.64%
DRW Securities, LLC
0.52%
Garrett (Scott T)
0.38%
기타
86.55%
주주
주주
비율
Wong (Hing C)
7.45%
Armistice Capital LLC
4.46%
Byam (Rebecca)
0.64%
DRW Securities, LLC
0.52%
Garrett (Scott T)
0.38%
기타
86.55%
주주 유형
주주
비율
Individual Investor
8.69%
Hedge Fund
4.85%
Investment Advisor
1.61%
Investment Advisor/Hedge Fund
0.21%
Research Firm
0.01%
기타
84.63%
기관 주식 보유
마지막 업데이트: Wed, Apr 1
마지막 업데이트: Wed, Apr 1
보고 기간
기관 수
보유 주식
비율
변동
2026Q1
39
465.64K
6.91%
+303.62K
2025Q4
36
125.21K
4.63%
+21.18K
2025Q3
35
36.93K
1.72%
-55.99K
2025Q2
40
613.16K
31.10%
+79.16K
2025Q1
40
480.61K
42.86%
-46.33K
2024Q4
37
23.10M
51.86%
+2.14M
2024Q3
33
21.13M
54.31%
+156.07K
2024Q2
33
21.19M
54.45%
+322.27K
2024Q1
34
20.93M
57.88%
+1.69M
2023Q4
33
19.30M
53.71%
+122.06K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Wong (Hing C)
501.91K
14.27%
--
--
Feb 17, 2026
Armistice Capital LLC
300.18K
8.54%
+300.18K
--
Dec 31, 2025
Byam (Rebecca)
43.01K
1.22%
--
--
Feb 17, 2026
DRW Securities, LLC
35.28K
1%
-48.16K
-57.71%
Dec 31, 2025
Garrett (Scott T)
25.50K
0.73%
--
--
Feb 17, 2026
Citadel Advisors LLC
22.16K
0.63%
+22.16K
--
Dec 31, 2025
Susquehanna International Group, LLP
20.07K
0.57%
+20.07K
--
Dec 31, 2025
Abante Asesores Gestión, S.G.I.I.C., S.A.
19.80K
0.56%
+19.80K
--
Dec 31, 2025
Geode Capital Management, L.L.C.
14.04K
0.4%
+3.04K
+27.60%
Dec 31, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
Apr 01, 2025
Merger
40→1
날짜
배당락일
유형
비율
Apr 01, 2025
Merger
40→1
